Vocal Fold Cysts Treatment & Management

  • Author: John Schweinfurth, MD; Chief Editor: Arlen D Meyers, MD, MBA   more...
 
Updated: Jun 25, 2010
 

Medical Therapy

The key to identifying intracordal cysts is minimizing surrounding edema and inflammation. Modified voice use, vocal hygiene, and, often, medication aid in accomplishing reduced edema and inflammation. Thus, the subtle stroboscopic appearance of a significant intracordal cyst may be revealed. Patients may be placed on a 2-week period of vocal rest, perhaps accompanied by a high-dose corticosteroid taper. Steroid treatment reduces the overlying and sometimes camouflaging inflammation and swelling while leaving the cyst unchanged, thus making its diagnosis easier.

Evaluating and treating any intercurrent medical conditions affecting the voice (eg, reflux laryngitis, allergic rhinitis) are also essential. In addition, patients with vocal fold cysts often have compounding functional issues that need to be addressed, both preoperatively and postoperatively, with expert speech-language intervention.

Next

Surgical Therapy

Surgery is reserved for patients with lesions that show no reversibility with exhaustive medical and speech therapy. Although nodules and polyps may respond to conservative management, vocal cysts typically do not. Delay in surgical treatment and continued trauma can potentially lead to progression of cyst formation and intracordal scarring. The goal of surgical excision is preservation of the mucosal cover with minimal disruption of the underlying tissue. In addition, the deep layers of the lamina propria harbor fibroblasts that produce extracellular proteins. Avoid this layer to prevent scarring along the vocal ligament and tethering of the mucosal cover. The microflap approach to the excision of benign laryngeal lesions was developed with these goals in mind (see Intraoperative details).

Diagnostic direct microlaryngoscopy should also be considered when the diagnosis is uncertain or when a neoplastic process cannot be excluded.

Previous
Next

Preoperative Details

Evaluate patients presenting with dysphonia through indirect laryngoscopy and videostroboscopy, with particular attention paid to vocal fold mobility, glottic closure, and the presence, amplitude, and symmetry of the vocal fold mucosal wave. Benign vocal lesions are first treated by reversing the conditions and patterns of abuse that initially created them. Surgery is reserved for patients with unresolving lesions that cause troublesome dysphonia. All known sources of mechanical trauma are maximally reduced prior to considering surgical therapy to determine reversibility and, hopefully, to prevent postoperative recurrence. Medical and speech therapy directed at reducing vocal trauma through improved technique and vocal hygiene are involved in reducing mechanical trauma. Surgical candidates must be willing to postpone speaking and singing engagements for at least 3 months postoperatively.

Previous
Next

Intraoperative Details

The lateral microflap is used when the lesion is adherent to the vocal ligament and the overlying mucosa is normal. The advantage of the lateral microflap is that the incision and the subsequent scar are lateral to the medial surface of the vocal fold. In addition, the uninvolved portion of the vocal ligament may be used to orient the flap, and dissection may proceed from known to unknown. The medial microflap is indicated for lesions that involve a discrete portion of the vocal fold and appear to separate easily from the underlying vocal ligament on palpation. This approach allows for a shorter flap and can be used to treat redundant or adherent mucosa overlying a lesion. At the conclusion of the procedure, a solution of triamcinolone acetate may be injected into the flap. This is thought to further minimize scar formation. With both techniques, most patients experience return of mucosal wave and are satisfied with voice quality.

Previous
Next

Postoperative Details

Place the patient on strict voice rest for 2 weeks after microflap surgery. Patients with more extensive dissections may be placed on a short course of corticosteroids. Administer a 7-day course of antibiotics and a mild narcotic for pain relief to all patients. Treat patients with symptoms or findings of laryngopharyngeal reflux with a proton-pump–inhibiting agent.

Previous
Next

Follow-up

Reexamine patients at 2, 4, 8, and 12 weeks postsurgery. At the 2-week postoperative visit, perform videostroboscopy and have the patient resume therapy with the speech pathologist. A gradual return to voice use occurs over the first few weeks, increasing by 5-minute intervals twice daily. Singers may begin to work with the vocal pedagogue (ie, singing teacher) at 1 month, but they are cautioned to decrease vocal work if they feel any discomfort or strain. Most patients can expect 90% of their functional surgical result at approximately 3 months.

Previous
Next

Complications

Complications are related either to laryngoscopy or to vocal fold mucosal injury. Pressure effects from suspension laryngoscopy may result in tongue numbness, altered taste, and oropharyngeal, mucosal, and dental injuries. Deep-plane dissection or exposure of the vocal ligament can result in scarring and fibrosis of the mucosa with loss of mucosal wave and glottal insufficiency. Injudicious use of the laser can result in a wide zone of thermal damage with mucosal scarring and fibrosis, unintended burn injuries, and endotracheal tube fires. The best way to treat scarring is to prevent it. Use of microflap techniques avoids a raw mucosal surface that heals by secondary intention. Avoidance of the deeper layers of the lamina propria and vocal ligament minimizes the fibroblastic response.

Previous
Next

Outcome and Prognosis

Using the microflap technique described above, Courey et al found that 85% of patients with an absent wave preoperatively regained their mucosal wave, while 97% percent of patients with an intact preoperative wave retained this important parameter.[1] Blinded comparison of preoperative and postoperative voice samples from this series showed that the postoperative voice was rated as better in 100% (48 of 48) of patients. Although long-term results in these patients remain excellent, continued emphasis should be placed on the prevention of pathology (eg, voice training, good vocal hygiene, maintenance of systemic health).

Previous
Next

Future and Controversies

Some authors have expressed concern that elevating a microflap may lead to disruption of the attachment of the basement membrane to the superficial layer of the lamina propria through interlinked collagen loops. The mini-microflap was described to minimize tissue manipulation and prevent possible basement membrane injury. The plane of the microflap is in the superficial layer of the lamina propria deep to the basement membrane and likely leaves these attachments untouched. This is demonstrated by the observation of blood vessels within the flap, which clearly reside deep to the basement membrane. Other authors have proposed entering the vocal fold through an anterior, submucosal approach through the thyroid cartilage that obviates the need for an incision in the epithelium. Endoscopes placed into the Reinke space in cadavers allowed for surgery of lesions of the lamina propria.[2] This approach could potentially minimize vocal scarring associated with mucosal incisions and raising subepithelial flaps.

Determining whether the traditional or newer mini-microflap procedures damage or protect the basement membrane or whether basement membrane injury hampers voice is difficult. Results with the microflap have been excellent, with return of good-to-excellent voice and mucosal wave in most patients. Use of the laser in the surgical treatment of benign nodules, polyps, or cysts to minimize scar formation is minimal.

Previous
 
Contributor Information and Disclosures
Author

John Schweinfurth, MD  Professor, Department of Otolaryngology, University of Mississippi Medical Center

John Schweinfurth, MD is a member of the following medical societies: American Academy of Otolaryngic Allergy, American Academy of Otolaryngology-Head and Neck Surgery, American Laryngological Association, American Medical Association, and Triological Society

Disclosure: Nothing to disclose.

Coauthor(s)

Robert H Ossoff, DMD, MD  Assistant Vice-Chancellor for Compliance and Corporate Integrity and Maness Professor of Laryngology and Voice, Vanderbilt Medical Center

Robert H Ossoff, DMD, MD is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, American Bronchoesophagological Association, American College of Chest Physicians, American College of Surgeons, American Laryngological Association, American Laryngological Rhinological and Otological Society, American Medical Association, American Rhinologic Society, American Society for Head and Neck Surgery, American Society for Laser Medicine and Surgery, Sigma Xi, and Southeastern Surgical Congress

Disclosure: Nothing to disclose.

Specialty Editor Board

Clark A Rosen, MD  Director, University of Pittsburgh Voice Center; Professor, Department of Otolaryngology and Communication Science and Disorders, University of Pittsburgh School of Medicine

Clark A Rosen, MD is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, American College of Surgeons, American Medical Association, and Pennsylvania Medical Society

Disclosure: Bioform Medical Consulting fee Consulting; Bioform Medical Consulting fee Speaking and teaching

Francisco Talavera, PharmD, PhD  Senior Pharmacy Editor, eMedicine

Disclosure: eMedicine Salary Employment

Robert M Kellman, MD  Professor and Chair, Department of Otolaryngology and Communication Sciences, State University of New York Upstate Medical University

Robert M Kellman, MD is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, American College of Surgeons, American Medical Association, American Neurotology Society, American Rhinologic Society, American Society for Head and Neck Surgery, Medical Society of the State of New York, and Triological Society

Disclosure: GE Healthcare Honoraria Review panel membership

Christopher L Slack, MD  Otolaryngology-Facial Plastic Surgery, Private Practice, Associated Coastal ENT; Medical Director, Treasure Coast Sleep Disorders

Christopher L Slack, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, and American Medical Association

Disclosure: Nothing to disclose.

Chief Editor

Arlen D Meyers, MD, MBA  Professor, Department of Otolaryngology-Head and Neck Surgery, University of Colorado School of Medicine

Arlen D Meyers, MD, MBA is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, and American Head and Neck Society

Disclosure: Covidien Corp Consulting fee Consulting; US Tobacco Corporation unstricted gift unknown; Axis Three Corporation Ownership interest Consulting; Omni Biosciences Ownership interest Consulting; Sentegra Ownership interest Board membership; Syndicom Ownership interest Consulting; Oxlo Consulting; Medvoy Ownership interest Management position; Cerescan Imaging Honoraria Consulting; GYRUS ACMI Honoraria Consulting

References
  1. Courey MS, Gardner GM, Stone RE, et al. Endoscopic vocal fold microflap: a three-year experience. Ann Otol Rhinol Laryngol. Apr 1995;104(4 Pt 1):267-73. [Medline].

  2. Hoffman HT, Bock JM, Karnell LH, et al. Microendoscopy of Reinke's space. Ann Otol Rhinol Laryngol. Jul 2008;117(7):510-4; discussion 515-6. [Medline].

  3. Courey MS, Garrett CG, Ossoff RH. Medial microflap for excision of benign vocal fold lesions. Laryngoscope. Mar 1997;107(3):340-4. [Medline].

  4. Courey MS, Shohet JA, Scott MA, et al. Immunohistochemical characterization of benign laryngeal lesions. Ann Otol Rhinol Laryngol. Jul 1996;105(7):525-31. [Medline].

  5. Gray S. Basement membrane zone injury in vocal nodules. In: Gauffin J, Hammarberg B, eds. Vocal Fold Physiology. San Diego: Singular Press; 1991.

  6. Gray SD, Hammond E, Hanson DF. Benign pathologic responses of the larynx. Ann Otol Rhinol Laryngol. Jan 1995;104(1):13-8. [Medline].

  7. Gray SD, Hirano M, Sato K. Molecular and cellular structure of vocal fold tissue. In: Gauffin J, Hammarberg B, eds. Vocal Fold Physiology. San Diego: Singular Press; 1991:1-35.

  8. Hirano M. Surgical anatomy and physiology of the vocal folds. In: Voice Surgery. St. Louis: Mosby-Year Book; 1993:125-58.

  9. Hirano M, Yoshida T, Hirade Y, et al. Improved surgical technique for epidermoid cysts of the vocal fold. Ann Otol Rhinol Laryngol. Oct 1989;98(10):791-5. [Medline].

  10. Rubin JS, Lee S, McGuinness J, et al. The potential role of ultrasound in differentiating solid and cystic swellings of the true vocal fold. J Voice. Jun 2004;18(2):231-5. [Medline].

  11. Sataloff RT. The professional voice. In: Cummings CW, Fredrickson JM, Haker LA, et al, eds. Otolaryngology: Head and Neck Surgery. Vol. 3. St. Louis: Mosby; 1986:2029-56.

  12. Sataloff RT, Spiegel JR, Heuer RJ, et al. Laryngeal mini-microflap: a new technique and reassessment of the microflap saga. J Voice. Jun 1995;9(2):198-204. [Medline].

Previous
Next
 
Indirect laryngoscopy of an intracordal cyst is shown. Note the appearance is similar to that of a nodule or polyp.
Note the translucent outline of the body of the cyst within the mucosal cover of the right true vocal fold. The articulatory surface of the cord is minimally disrupted.
This patient had an essentially normal speaking voice but complained of fatigue and loss of vocal range. Note the translucent quality of the mucosal cover.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.